(News Bulletin 247) – The Boiron family announced on Tuesday evening the launch of a simplified takeover bid for the entire capital of its pharmaceutical laboratory. When it resumed trading, the Boiron stock approached the price of 50 euros offered to minority shareholders.

Resumption of trade in sharp increase for Boiron. On the Paris Stock Exchange, the title of the pharmaceutical laboratory, which had been suspended from trading since Tuesday noon, rose 24.3% to 49.05 euros to approach the price of the offer proposed by the Boiron family to minority shareholders. .

The Boiron family, which holds 69.9% of the capital and 78.3% of the voting rights of Boiron, announced Tuesday shortly before the closing of the Paris market the launch of a simplified public offer (OPAS) on the pharmaceutical laboratory with a view to repurchasing the securities that it does not yet hold.

The operation “would be at a price of 39.64 euros per Boiron share after deduction of an exceptional dividend of 10.36 euros per Boiron share”, specifies the press release. The company explains that this price of 39.64 euros per share net of the dividend would represent a premium of 36% compared to the closing on Monday.

The majority shareholder has teamed up with the investment company specializing in health EW Healthcare with a view to delisting the company if the conditions are met.

A number of listing exits always higher than IPOs

As for the seed company Vilmorin last spring, the Boiron family justifies this operation by the lack of interest presented by a listing of its pharmaceutical laboratory on the stock market. “The status of unlisted company appears much more suited to the development of the Boiron group, which wishes to invest significantly in the medium term,” adds the group.

The Rhone group is therefore about to say goodbye to the Stock Exchange, 36 years after its listing on the Second Market of the Lyon Stock Exchange, in June 1987, when the regional Stock Exchanges were still part of the French financial landscape.

Boiron is therefore preparing to join the procession of future departures from the Paris Stock Exchange, already well fleshed out with the announcements of exits from the rating of Vilmorin, the technology group Keyrus or the robotics specialist Balyo. At the end of June, it was Paragon ID, the identification solutions specialist, which announced that it was the subject of a simplified takeover bid from Grenadier Holdings, its majority shareholder.

The Parisian rating is therefore visibly thinning while at the same time the number of IPOs is still insufficient to make up for these departures. Since the beginning of the year, 7 companies have left the Parisian quotation – Groupe Flo having inaugurated the departures of 2023 from the month of February – when only 3 companies (Lepermislibre, Florentaise and Mon courtier énergie) have taken their first stock market steps in the interval. A number which could rise to 4, in the event of success of the Osmsosun offer, the results of which will be known this Wednesday evening.